MEI Pharma (MEIP) – Corporate News
-
MEI Pharma (MEIP) Reports Initial Data from Study of ME-344 in Combination with Bevacizumab
-
MEI Pharma (MEIP) Board Aligns on Strategy to Advance Voruciclib and ME-344
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MEIP Stock Lookup